Back to Search
ANTHONY SEBBA, MD
MD
Rheumatology Physician
NPI: 1629077243Individual
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
ME0070361(FL)
Research & Publications (14)
Tocilizumab: the first interleukin-6-receptor inhibitor.
PMID 18653811·Am J Health Syst Pharm·2008
6-review
Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis.
PMID 15706659·Curr Med Res Opin·2004
3-trial
Ibandronate dose response is associated with increases in bone mineral density and reductions in clinical fractures: results of a meta-analysis.
PMID 19049913·Bone·2009
1-meta
Osteoporosis: how long should we treat?
PMID 18971678·Curr Opin Endocrinol Diabetes Obes·2008
6-review
Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.
PMID 18405784·Clin Ther·2008
6-review
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study.
PMID 19297346·Ann Rheum Dis·2010
4-observational
Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates.
PMID 19141590·J Clin Endocrinol Metab·2009
8-other
Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
PMID 19487264·J Rheumatol·2009
4-observational
Vertebral fracture risk is reduced in women who lose femoral neck BMD with teriparatide treatment.
PMID 19113918·J Bone Miner Res·2009
2-rct
Comparing non-vertebral fracture risk reduction with osteoporosis therapies: looking beneath the surface.
PMID 19052831·Osteoporos Int·2009
6-review
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
PMID 16936327·Rheumatology (Oxford)·2007
4-observational
Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years.
PMID 16636120·J Clin Endocrinol Metab·2006
4-observational
Optimizing administration of bisphosphonates in women with postmenopausal osteoporosis.
PMID 16053341·Treat Endocrinol·2005
6-review
Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.
PMID 12115175·Arthritis Rheum·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 33920 US HIGHWAY 19 NORTH, SUITE 241
PALM HARBOR, FL 34684 - Phone
- (727) 773-9793
Quick Facts
- NPI
- 1629077243
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile